<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910342560-nanobiotix-announces-protocol-amendment-to-ongoing-global-phase-3-head-and-neck-cancer-study</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910342587-nanobiotix-annonce-un-amendement-du-protocole-de-l-tude-mondiale-de-phase-3-sur-le-cancer-de-la-t-te-et-du-cou</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910342532-edgesource-corporation-acquires-lyteworx-automation-systems-deepening-its-defense-and-intelligence-mission-capabilities</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:28:35+00:00</news:publication_date>
        <news:title>Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ba7fdda5-6ced-4314-801e-44f9e00da542/small/edgesource-logo-pr-1200-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910342447-jiade-limited-announces-pricing-of-up-to-12-0-million-registered-direct-offering</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:10:00+00:00</news:publication_date>
        <news:title>JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/66c132ba-862c-42c5-92fc-aab67a82bf74/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910342356-new-publication-demonstrates-tlx250-px-zircaix-potential-in-diagnosing-kidney-cancers-beyond-ccrcc</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:00:00+00:00</news:publication_date>
        <news:title>New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333422-tango-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:31:00+00:00</news:publication_date>
        <news:title>Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6e37a27-2e33-43bb-ae05-bfb0dedbf190/small/tango-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333352-teva-to-present-at-the-bofa-securities-health-care-conference</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Teva to Present at the BofA Securities Health Care Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333368-vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333377-cellectis-to-report-first-quarter-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Cellectis to Report First Quarter Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333384-cellectis-publiera-ses-r-sultats-financiers-du-premier-trimestre-le-11-mai-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a84ce25b-a774-4635-9b79-d45241f5decc/small/cellectis-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333396-crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333425-microvast-schedules-first-quarter-earnings-call</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Microvast Schedules First Quarter Earnings Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df776795-0f3f-47ee-8207-63d8c61b98bb/small/microvast-tag-bluewhite-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333429-opus-genetics-announces-fda-acceptance-of-opgx-lca5-into-rare-disease-evidence-principles-rdep-program</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333432-eton-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333456-bioage-to-host-r-d-day-focused-on-nlrp3-inhibition-on-may-8-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>BioAge to Host R&amp;D Day Focused on NLRP3 Inhibition on May 8, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333491-cvrx-announces-first-patient-enrollment-in-benefit-hf-a-landmark-heart-failure-trial-evaluating-barostim-in-significantly-expanded-population</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:30:00+00:00</news:publication_date>
        <news:title>CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333399-anaptys-to-participate-at-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:15:00+00:00</news:publication_date>
        <news:title>Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910333489-kuvi-integrates-with-kucoin-broker-pro-to-advance-agentic-finance-adoption</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:15:00+00:00</news:publication_date>
        <news:title>Kuvi Integrates with KuCoin Broker Pro to Advance Agentic Finance Adoption</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/eff106d2-82fe-40b8-a438-742d86074e01/small/555-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324529-3-e-network-technology-signs-1-3m-convertible-note-agreement-with-institutional-investor</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:10:00+00:00</news:publication_date>
        <news:title>3 E Network Technology Signs 1.3M Convertible Note Agreement with Institutional Investor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8f4e21c2-5e2c-4ce6-88ee-66c06500e891/small/22222-2026-01-14-183954-150-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324540-kyntra-bio-to-report-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Kyntra Bio to Report First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9105c1e9-d9e3-4b68-9fc8-261fed7db250/small/kyntra-bio-r-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324550-tactile-systems-technology-inc-reports-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/7ecb6926-a715-4305-979c-a80795dbab83/small/tactile-medical-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324583-rumble-announces-timing-of-first-quarter-2026-earnings-release-and-conference-call</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Rumble Announces Timing of First Quarter 2026 Earnings Release and Conference Call</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e41a1c60-94cb-441c-8c8e-c8202cad5bce/small/image1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324622-clip-money-inc-announces-amendment-of-unsecured-convertible-notes</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Clip Money Inc. Announces Amendment of Unsecured Convertible Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/80569958-6412-49bc-802d-e98810b40181/small/logo-800-300dpi-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324625-everquote-announces-first-quarter-2026-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>EverQuote Announces First Quarter 2026 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/86005bfc-f760-4c2f-9bfc-d896152a9bea/small/everquote-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324647-silvaco-announces-participation-at-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Silvaco Announces Participation at Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/86c898ba-7d91-45b3-9db0-edb7315ddaba/small/silvaco-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324650-capricor-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-recent-corporate-update-on-may-12</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/16ce4387-5b8f-447c-96b8-7c453633f9bf/small/getimage-48-768x274-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324654-lexicon-pharmaceuticals-announces-100-million-loan-facility-with-hercules-capital</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324720-aktis-oncology-initiates-phase-1b-clinical-trial-for-aky-2519-a-b7-h3-miniprotein-radioconjugate-in-metastatic-castration-resistant-prostate-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324766-oric-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-updates</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:05:00+00:00</news:publication_date>
        <news:title>ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324758-ocugen-announces-private-offering-of-115-million-of-convertible-senior-notes</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:51+00:00</news:publication_date>
        <news:title>Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324495-praxis-precision-medicines-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-and-participate-in-upcoming-investor-conference</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324509-fibrobiologics-reports-preclinical-data-showing-fibroblast-spheroids-may-actively-reprogram-the-burn-wound-environment-to-drive-healing-and-reduce</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324510-biodesix-announces-first-quarter-2026-results-and-highlights</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Biodesix Announces First Quarter 2026 Results and Highlights</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b2fd8e3c-ff04-47d9-938d-93c9c961ccc3/small/bdsx-logo-1200x240-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324629-hemab-therapeutics-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:01:00+00:00</news:publication_date>
        <news:title>Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/M2UyM2ExNWYtYTJjYi00M2RhLTkwZGEtNjZlYTUyMzI4NTI4LTEzMjE4MjEtMjAyNi0wNS0wNC1lbg==/tiny/Hemab-Therapeutics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324596-cytokinetics-to-announce-topline-results-from-acacia-hcm-the-pivotal-phase-3-clinical-trial-of-aficamten-in-patients-with-non-obstructive</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:00:00+00:00</news:publication_date>
        <news:title>Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324602-visionary-holdings-inc-announces-receipt-of-nasdaq-delisting-determination-letter-related-to-delinquent-listing-fees</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T20:00:00+00:00</news:publication_date>
        <news:title>Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Mzc5NzU4NDctOGU1ZC00Y2JjLWE1YjEtMjkxMmYzYjM3M2Q3LTEzMTczMjYtMjAyNi0wNS0wNC1lbg==/tiny/Visionary-Holdings-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910324663-crn-recognizes-11-employees-at-climb-channel-solutions-on-the-2026-women-of-the-channel-list-and-names-climb-s-chief-marketing-officer-as-one-of-the</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:29:34+00:00</news:publication_date>
        <news:title>CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7f62397-551b-4c5f-ac67-cd3baeeb84e4/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910315198-roadzen-announces-pricing-of-8-million-registered-direct-offering-of-ordinary-shares</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:27:19+00:00</news:publication_date>
        <news:title>Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5101ee32-4aaf-4552-aa26-c4ed796caf72/small/roadzen-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910315145-liabilityscore-announces-new-platform-to-bring-credit-score-logic-to-contract-risk-built-for-small-businesses-not-lawyers</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T19:20:00+00:00</news:publication_date>
        <news:title>LiabilityScore Announces New Platform to Bring Credit-Score Logic to Contract Risk — Built for Small Businesses, Not Lawyers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3240312/Commercial-Lease-Score.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910306646-sana-commerce-appoints-brian-plackis-cheng-as-ceo</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T18:20:25+00:00</news:publication_date>
        <news:title>Sana Commerce Appoints Brian Plackis Cheng as CEO</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/ec9f9caa-d98f-47e3-acc7-b19eaab978ae/small/sana-logotype-red-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910298991-michael-haske-to-become-isolved-ceo-as-company-embarks-on-next-phase-of-ai-led-growth</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T18:00:00+00:00</news:publication_date>
        <news:title>Michael Haske to Become isolved CEO as Company Embarks on Next Phase of AI-Led Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c7803669-a575-4be5-a22a-b9982b790c1c/small/isolved-logo-color-pos-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910298983-amazon-one-medical-glp-1-program-evaluated-how-the-new-program-works-what-it-costs-and-what-cash-pay-patients-should-know-first</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:51:04+00:00</news:publication_date>
        <news:title>Amazon One Medical GLP-1 Program Evaluated: How the New Program Works, What It Costs, and What Cash-Pay Patients Should Know First</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee6fb8bf-1ad4-4b37-8ad6-34f3692f808e/medium/direct-meds.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910291456-admaxxer-surpasses-5-000-active-brands-and-1-2-billion-in-tracked-gmv-reinforcing-its-position-as-a-leading-dtc-analytics-and-ai-ad-operations</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:05:00+00:00</news:publication_date>
        <news:title>Admaxxer Surpasses 5,000 Active Brands and $1.2 Billion in Tracked GMV, Reinforcing Its Position as a Leading DTC Analytics and AI Ad Operations Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3248977/Admaxxer-Surpasses-5%2C000-Active-Brands-and-%241.2-Billion-in-Tracked-GMV%2C-Reinforcing-Its-Position-as-a-Leading-DTC-Analytics-and-AI-Ad-Operations-Platform-Press.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910291473-eascra-biotech-welcomes-dr-anne-yau-as-life-science-research-scientist</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T17:04:04+00:00</news:publication_date>
        <news:title>Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1eda41c1-8c5d-43f0-9198-b0a1570f47e6/medium/dr-anne-yau.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910278459-deepinfra-closes-107m-series-b-to-power-production-scale-ai-inference</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>DeepInfra Closes $107M Series B to Power Production-Scale AI Inference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f36602ae-b2cf-4f29-be62-c811818f6e32/small/deepinfra-logo-horizontal-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910278468-samba-tv-bolsters-technical-leadership-with-promotion-of-jaya-aswani-to-cto-and-appointment-of-ramzi-nasr-as-vp-of-engineering</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Samba TV bolsters technical leadership with promotion of Jaya Aswani to CTO and appointment of Ramzi Nasr as VP of Engineering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/25a74fa7-09fe-4ed7-8189-1587683af145/small/samba-tv-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910278471-carahsoft-recognized-in-2025-broadcom-partner-awards</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Carahsoft Recognized in 2025 Broadcom Partner Awards</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ee2f2b02-4089-4a15-93fa-0956daf4ad82/small/carahsoft-blue-logo-web-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910278515-asentum-announces-ase-token-presale-ahead-of-post-quantum-mainnet-release</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T16:00:00+00:00</news:publication_date>
        <news:title>Asentum Announces $ASE Token Presale Ahead of Post-quantum Mainnet Release</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ff6e601c-253e-46a5-aeb1-de722f4fdcd5/small/screenshot-2026-04-30-104146-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910278486-microcloud-hologram-inc-efficient-deterministic-quantum-state-preparation-algorithm-based-on-decision-diagrams</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:40:00+00:00</news:publication_date>
        <news:title>MicroCloud Hologram Inc. Efficient Deterministic Quantum State Preparation Algorithm Based on Decision Diagrams</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/OWYyYTNlYjctOWMzYi00ZmU4LWEyMTktOTQwOWU0MGM5Y2M1LTEzMTA4OTctMjAyNi0wNS0wNC1lbg==/tiny/MicroCloud-Hologram-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910278494-focus-school-software-celebrates-20-years-as-a-leading-national-provider-of-k-12-technology-solutions</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:34:49+00:00</news:publication_date>
        <news:title>Focus School Software Celebrates 20 Years as a Leading National Provider of K-12 Technology Solutions</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/559730d4-2aa4-418f-81fa-507e7f90d91b/small/focus-logo-1200x630-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910272579-warmysender-reaches-15-000-users-reinforcing-position-as-top-instantly-alternative</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:15:00+00:00</news:publication_date>
        <news:title>WarmySender Reaches 15,000 Users, Reinforcing Position as Top Instantly Alternative</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3248932/WarmySender-Reaches-15%2C000-Users%2C-Reinforcing-Position-as-Top-Instantly-Alternative-Press.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910272589-flyguys-launches-reality-behind-the-flight-a-new-podcast-exploring-the-world-of-reality-data-capture</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:11:34+00:00</news:publication_date>
        <news:title>FlyGuys Launches “Reality: Behind the Flight,” A New Podcast Exploring the World of Reality Data Capture</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDIxMjMxODItNjljMi00ZmM3LTgyNDMtMzVlZmE5MWI0ODQxLTUwMDE2MjAxNy0yMDI2LTA1LTA0LWVu/tiny/FlyGuys-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910272515-intuitive-ai-achieves-aws-data-and-analytics-competency-as-enterprises-reassess-the-foundations-of-ai</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T15:00:00+00:00</news:publication_date>
        <news:title>Intuitive.ai achieves AWS Data and Analytics Competency as Enterprises Reassess the Foundations of AI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3fc27a9a-561c-455c-b3a6-6a83ba8090b8/small/intuitive-logo-secondary-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910272541-sophos-celebrates-22-leaders-named-to-2026-crn-women-of-the-channel-list</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:56:39+00:00</news:publication_date>
        <news:title>Sophos Celebrates 22 Leaders Named to 2026 CRN Women of the Channel List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/35db908a-b7b8-4ce0-b920-69875da346ba/small/sophos-1200x628-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910266621-jama-software-launches-model-context-protocol-mcp-server</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:45:00+00:00</news:publication_date>
        <news:title>Jama Software Launches Model Context Protocol (MCP) Server</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0f19efa9-cf4d-43a0-9f83-4d48de067aec/small/jama-software-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910266571-flexera-channel-leaders-spotlighted-across-the-crn-2026-women-of-the-channel-list</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:30:00+00:00</news:publication_date>
        <news:title>Flexera Channel Leaders Spotlighted Across the CRN® 2026 Women of the Channel List</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/691aa193-5f37-4e50-8fec-38e34f7a5e43/small/97e88b00-acec-4133-812f-8213dba8f99b-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910262632-mmi-s-symani-surgical-system-treats-first-alzheimer-s-patient-in-groundbreaking-remind-study</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:10:00+00:00</news:publication_date>
        <news:title>MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9325bed-8fcb-4abf-b66e-6f076014b0fb/small/mmi-logo-stacked-tagline-positive-rgb1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910262667-owlting-group-nasdaq-owls-launches-owlpay-agent-wallet-targeting-the-emerging-multi-trillion-dollar-agentic-commerce-economy</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:07:50+00:00</news:publication_date>
        <news:title>OwlTing Group (NASDAQ: OWLS) Launches OwlPay Agent Wallet, Targeting the Emerging Multi-Trillion-Dollar Agentic Commerce Economy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5a79481c-55d1-4e33-9f88-950aa88aeec5/medium/owlting-built-the-wallet-the-agentic-economy-needs-self-cust.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910262611-research-on-new-class-of-treatments-for-ovarian-cancer-receives-725-000-in-funding-from-ovarian-cancer-canada-to-become-clinical-trial-ready</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWY2NGZiYWEtODcyZC00Y2I5LThkZGEtYmM5ZjlkYzFkNDMzLTEzMTI5NjUtMjAyNi0wNS0wNC1lbg==/tiny/Ovarian-Cancer-Canada.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910262624-inqi-launches-ai-native-property-intelligence-platform-with-new-editor-and-expanded-iq-apps</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>InQI Launches AI-Native Property Intelligence Platform with New Editor and Expanded IQ Apps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3244005/inqi_image_2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910262626-spring-allergies-hit-lungs-hard-doctor-of-pharmacy-explains-what-actually-helps</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T14:00:00+00:00</news:publication_date>
        <news:title>Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/13a92186-d8d0-4494-9e0a-5fc1d2e363ee/small/betterbrand-logo-new-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910258304-talkdesk-announces-new-integration-to-deliver-unified-healthcare-experience-and-outcomes-analytics</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:32:15+00:00</news:publication_date>
        <news:title>Talkdesk announces new integration to deliver unified healthcare experience and outcomes analytics</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b806fec8-0de9-496b-9ddc-7775b20acf14/small/talkdesk-logo-png.PNG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910258255-coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/07437af0-8ae3-48cf-952b-18bc6b99ca7c/small/coherus-onc-logo-rgb-150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910258274-intouch-insight-study-finds-mobile-ordering-success-hinges-on-reliability-not-speed</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:30:00+00:00</news:publication_date>
        <news:title>Intouch Insight Study Finds Mobile Ordering Success Hinges on Reliability, Not Speed</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MDhhNGZhN2MtZWVhZi00MWIwLTkxZDEtNmUyMjQ1ODIxMzM0LTUwMDE1NjYxNy0yMDI2LTA1LTA0LWVu/tiny/Intouch-Insight.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910258286-alpha-tau-announces-100-local-disease-control-rate-and-favorable-safety-profile-observed-in-alpha-dart-pancreatic-cancer-trials-presented-at-ddw</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:17:21+00:00</news:publication_date>
        <news:title>Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910258285-alternative-ballistics-corporation-otcqb-albc-to-host-corporate-update-call-on-may-7-2026-at-8-30-am-et</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:15:00+00:00</news:publication_date>
        <news:title>Alternative Ballistics Corporation (OTCQB: ALBC) to Host Corporate Update Call on May 7, 2026 at 8:30 AM ET</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/6f3eddb5-8d1a-420e-b07f-3e21f440c666/small/albc-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252863-prismatic-launches-skills-for-claude-code-to-help-developers-ship-integrations-faster</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:05:00+00:00</news:publication_date>
        <news:title>Prismatic Launches Skills for Claude Code to Help Developers Ship Integrations Faster</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3ffa5f28-f782-4562-9961-b68fe61d97c2/medium/prismatic-launches-skills-for-claude-code.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910253033-greece-launches-world-s-first-national-wildfire-satellite-system-with-ororatech</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:04:00+00:00</news:publication_date>
        <news:title>Greece Launches World’s First National Wildfire Satellite System with OroraTech</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f405d4dd-2633-4e23-8086-bbaa6bf83b25/medium/ororatech-s-hellenic-fire-system.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910253114-aura-biosciences-announces-pricing-of-260-million-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:03:06+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Pricing of $260 Million Public Offering of Common Stock and Pre-funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252843-operant-ai-launches-endpoint-protector-securing-shadow-ai-coding-agents-and-mcp-across-the-enterprise</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Operant AI Launches Endpoint Protector: Securing Shadow AI, Coding Agents, and MCP Across the Enterprise</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cf992a83-aa53-4fbe-8acd-1dbc5d0de200/small/operant-black-logo-master-png-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252851-asus-releases-2026-future-of-small-business-report</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>ASUS Releases 2026 Future of Small Business Report</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3239907/Future-of-SMB-Report.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252862-carnosyn-brands-expands-tribsyn-applications-across-beverage-dairy-and-medical-nutrition</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/4b40dd5b-0137-41f8-83de-422e4b4f3196/small/nai-full-logo-green2-0-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252869-oncolytics-biotech-reports-durable-responses-in-second-line-ras-mutant-mss-colorectal-cancer</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f0121259-b2be-4290-90a3-0d2c3b243aed/small/oncolytics-biotech-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252951-turtle-beach-corporation-restructures-credit-facilities-to-enhance-capital-return-flexibility</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Turtle Beach Corporation Restructures Credit Facilities to Enhance Capital Return Flexibility</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8a9689c-6753-486d-b902-84d519018cbe/small/turtlebeachcorp-logo-stacked-blk-28-11-2023-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252971-fate-therapeutics-announces-three-presentations-at-the-2026-asgct-annual-meeting-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T13:00:00+00:00</news:publication_date>
        <news:title>Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910253027-quantum-x-labs-files-u-s-patent-application-for-high-precision-quantum-atomic-clock-for-potential-use-in-the-aerospace-defense-industries</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:52:00+00:00</news:publication_date>
        <news:title>Quantum X Labs Files U.S. Patent Application for High Precision Quantum Atomic Clock for Potential Use in the Aerospace &amp; Defense Industries</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a0abc50a-ff3e-420e-9e21-807bbc6417cd/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910253043-gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:47:47+00:00</news:publication_date>
        <news:title>Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910253010-polyrizon-announces-u-s-patent-expansion-for-its-intranasal-drug-delivery-platform</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:45:00+00:00</news:publication_date>
        <news:title>Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/YWIxMzIzNDgtN2UwNy00NTAyLThjZDMtZWMwNGFjZTdmNWJhLTUwMDEyOTIyMy0yMDI2LTA1LTA0LWVu/tiny/Polyrizon-Ltd-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910252891-aitx-to-present-at-the-ld-micro-invitational-xvi</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:40:00+00:00</news:publication_date>
        <news:title>AITX to Present at the LD Micro Invitational XVI</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/882a78f6-94c4-4a5c-a750-564a6dea2bb5/small/aitx-logo-1920x1080-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247553-mapi-pharma-explores-u-s-aseptic-manufacturing-facility-to-support-growing-demand-for-aseptic-and-long-acting-generic-and-innovative-injectables</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a15e698a-0f26-4d44-bf6a-78b7ae34d25d/small/mapi-pharma-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247597-abeona-therapeutics-announces-date-of-first-quarter-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Abeona Therapeutics® Announces Date of First Quarter Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247608-satellogic-expands-global-sales-force-with-senior-defense-and-intelligence-industry-veterans</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d2d0c386-2a99-4434-aa48-fc69a11ff8a7/small/satellogic-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247610-fibrobiologics-announces-release-of-cywc628-drug-product-for-phase-1-2-diabetic-foot-ulcer-clinical-trial</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247630-fortress-biotech-to-participate-in-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d82bf2ce-81b7-4989-9e6b-08e6bb6e1f95/small/fortressbio1-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247641-service-robotics-growth-accelerates-as-global-demand-fuels-strategic-expansion</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/45ff7033-6ad2-41ba-bbd1-912eb2907b3e/small/ainewswire-002-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247668-liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f7659070-cc55-4e68-ae70-33013e7df72c/small/liquidia-new-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247674-newgen-provides-update-on-fiscal-year-2025-results-and-strategic-progress</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ZWQwY2VjNmQtYTdlZi00YTUxLTg3NmItMmI3OWVkMTQ5MGQ4LTEyOTcwMTEtMjAyNi0wNS0wNC1lbg==/tiny/NewGenIvf-Limited.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910247689-axe-compute-inc-nasdaq-agpu-ceo-chris-miglino-to-appear-on-schwab-network-may-4-and-cheddar-may-6</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:30:00+00:00</news:publication_date>
        <news:title>Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242598-candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:05:00+00:00</news:publication_date>
        <news:title>Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242367-proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242372-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242419-evaxion-to-announce-business-update-and-first-quarter-2026-financial-results-on-may-7-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242435-recludix-pharma-announces-upcoming-oral-presentations-on-preclinical-data-for-oral-stat6-inhibitor-rex-8756-and-topical-stat-1-3-inhibitors-at-the</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NDM5ZGUzYTItNGI0Zi00N2Y3LWE3Y2QtZmViNDYyN2I1ZWRjLTEyMzYyMjItMjAyNi0wNS0wNC1lbg==/tiny/Recludix-Pharma-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242438-rhythm-pharmaceuticals-announces-new-data-presentations-in-acquired-hypothalamic-obesity-at-pediatric-endocrine-society</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242442-spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242445-zoom-recognizes-the-rise-of-ai-powered-businesses-of-one-with-inaugural-solopreneur-50</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/1a5e6f52-9a8e-432b-84cc-7dfb0e6623e2/small/logo-zm-app-icon-container-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242449-kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242457-4dmt-to-participate-in-upcoming-investor-conferences</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>4DMT to Participate in Upcoming Investor Conferences</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242470-valitor-presents-preclinical-data-demonstrating-superior-durability-with-six-month-treatment-protocol-of-vltr-559-to-treat-wet-amd</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242472-applied-digital-announces-300-million-senior-secured-bridge-facility</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Applied Digital Announces $300 Million Senior Secured Bridge Facility</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a09f7f80-1e66-44ed-b53a-6007ec7be92a/small/applied-digital-logo-horizontal-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242494-tessell-appoints-matt-mcdonough-and-jeffrey-carter-to-executive-team-to-accelerate-enterprise-database-modernization</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Tessell Appoints Matt McDonough and Jeffrey Carter to Executive Team to Accelerate Enterprise Database Modernization</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/503f121a-0162-4ce3-84b3-ae5e04dc98e5/medium/jeff-carter-chief-strategy-officer.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242516-kaltura-open-sources-suite-of-ai-agent-skills-enabling-any-ai-agent-to-build-intelligent-rich-media-digital-experiences</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Kaltura Open-Sources Suite of AI Agent Skills, Enabling Any AI Agent to Build Intelligent Rich-Media Digital Experiences  </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242538-lifeward-announces-new-rewalk-data-presented-at-asia-2026-conference-demonstrating-a-comprehensive-longitudinal-safety-analysis-for-a-powered</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242564-atsena-presents-positive-interim-six-month-results-from-part-b-of-phase-1-2-3-lighthouse-trial-evaluating-atsn-201-in-patients-with-x-linked</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242567-rocket-doctor-ai-reports-strong-2025-results-validating-physician-led-model-with-key-u-s-payer-contracts-and-ai-innovation</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242574-after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242582-legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242595-swarmer-partners-with-rakuten-to-enter-japan-s-advanced-autonomy-market</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Swarmer Partners With Rakuten to Enter Japan&#39;s Advanced Autonomy Market</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/46b28796-9654-4d2b-89db-91de399ba76a/small/swarmer-logo-dark-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910242608-ruanyun-edai-technology-s-saudi-rhq-signs-mou-with-wadi-makkah-a-subsidiary-of-umm-al-qura-university</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T12:00:00+00:00</news:publication_date>
        <news:title>Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/0b7372f3-6354-4bba-acc5-bb10b1de4c3a/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237832-macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237841-bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237849-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237860-palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237897-earthdaily-advancing-daily-global-measurement-of-planetary-change-with-six-satellites-launched</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/63895f31-922c-451d-894e-110f2f640ad9/medium/earthdaily-satellite-deploys.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237911-windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acting-immunology-therapies-with-best-in-disease-potential</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:30:00+00:00</news:publication_date>
        <news:title>Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/Nzk5NDkzNGQtNWZiNi00MGZkLTg2ZTAtYzViNDkwNTJjOTVmLTUwMDEzMTYxMS0yMDI2LTA1LTA0LWVu/tiny/Windward-Bio.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237925-micropolis-robotics-unveils-new-next-generation-high-endurance-robot-at-the-make-it-in-the-emirates-2026-industry-exhibition</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:29:19+00:00</news:publication_date>
        <news:title>Micropolis Robotics Unveils New, Next-Generation, High-Endurance Robot at the Make it in the Emirates 2026 Industry Exhibition</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ffdb8f0a-5da0-4cdc-9a97-852140e69d8b/medium/m1-5.JPG</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237843-cartesian-therapeutics-announces-new-employment-inducement-grants</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Cartesian Therapeutics Announces New Employment Inducement Grants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237845-nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910237870-kraig-biocraft-laboratories-launches-april-may-production-cycle-following-record-spider-silk-output</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:05:00+00:00</news:publication_date>
        <news:title>Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233519-ardena-strengthens-executive-team-to-drive-its-next-phase-of-growth</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Ardena Strengthens Executive Team to Drive its Next Phase of Growth</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/eddef504-18ee-4f10-8442-9e61ef77e262/medium/ardena-appoints-cfo-and-cco.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233520-indivior-announces-175-million-accelerated-share-repurchase</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Indivior Announces $175 Million Accelerated Share Repurchase</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233589-advanced-technology-recycling-atr-announces-that-they-are-now-offering-wholesale-electronics-to-the-general-public-through-their-online-auction-site</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/437d4f24-24b9-4cd4-961b-ea5dd0ab80ce/small/atr-logo-with-registered-trademark-badge-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233590-biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233621-tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233629-krystal-biotech-announces-first-quarter-2026-financial-and-operating-results</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Krystal Biotech Announces First Quarter 2026 Financial and Operating Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233642-10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-line-with-functional-n-a-and-low-sugar-cocktails</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5e71b27b-1cc8-4780-8689-8d8d6ae86236/medium/clean-slate-and-salty-sips.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233645-seres-therapeutics-presents-preclinical-data-at-digestive-disease-week-ddw-2026-supporting-ser-603-a-next-generation-cultivated-live-biotherapeutic</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233649-centrum-launches-newly-reformulated-adults-50-complete-multivitamin-with-clinically-shown-cognitive-benefits</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/395df94a-8079-4f58-9b54-df434e56ec33/medium/centrum-adults-50-complete-multivitamin.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233653-centrum-lance-sa-multivitamine-compl-te-adultes-50-nouvellement-reformul-e-avec-des-bienfaits-cognitifs-d-montr-s-cliniquement</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/abbbfaf3-e52b-413c-9ded-52f74cf50911/medium/centrum-multivitamine-complete-pour-adultes-50.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233661-genyro-announces-new-paper-demonstrating-how-sidewinder-technology-democratizes-dna-construction-at-scale-and-facilitates-ai-driven-protein-design</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/346f123b-cc5d-4de0-a31f-9c4f1315c070/medium/genyro-co-founders.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233678-seer-announces-appointment-of-anthony-bazarko-as-chief-commercial-officer</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/ecdddbc3-8a58-4cba-a4a1-33971e79339a/medium/anthony-bazarko.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233683-istios-health-partners-with-care-id-to-expand-national-infectious-disease-clinical-research-network</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/MTI0OGVmYTMtNmZkNC00ODA4LWJlNzUtNTYxODJlODcxNDBmLTEzMTYxMjEtMjAyNi0wNS0wNC1lbg==/tiny/Istios-Health.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233687-adma-biologics-announces-fda-approval-to-expand-the-label-for-asceniv-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233694-meet-sprysite-the-website-builder-and-marketing-platform-redefining-small-business-websites</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T11:00:00+00:00</news:publication_date>
        <news:title>Meet SprySite: The Website Builder and Marketing Platform Redefining Small Business Websites</news:title>
      </news:news>
        <image:image>
          <image:loc>https://pressranger.s3.us-west-1.amazonaws.com/3244560/sprypro.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233575-descartes-sets-date-to-announce-first-quarter-fiscal-2027-financial-results</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:45:00+00:00</news:publication_date>
        <news:title>Descartes Sets Date to Announce First Quarter Fiscal 2027 Financial Results</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2fab20c0-6dcb-4891-840a-37d0d482f33a/small/descartes-systems-group-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910233704-cabaletta-bio-announces-pricing-of-150-million-underwritten-offering</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:35:54+00:00</news:publication_date>
        <news:title>Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910224348-aura-biosciences-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:03:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910224335-aura-biosciences-announces-ceo-transition-as-company-advances-phase-3-compass-trial-toward-enrollment-completion</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:01:00+00:00</news:publication_date>
        <news:title>Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910224345-scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T10:00:00+00:00</news:publication_date>
        <news:title>Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the…</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910216010-what-is-the-best-internet-solution-for-business-travel-why-holafly-for-business-is-becoming-the-preferred-choice-for-global-companies</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:54:07+00:00</news:publication_date>
        <news:title>What is the best internet solution for business travel? Why Holafly for Business is becoming the preferred choice for global companies</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/ff9372ad-41f6-4acc-8266-5578d80cc425/medium/why-holafly-for-business-is-becoming-the-preferred-choice-fo.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910206820-virtune-ab-publ-virtune-hat-die-monatliche-neugewichtung-f-r-april-2026-des-virtune-crypto-altcoin-index-etps-durchgef-hrt</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für April 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910206825-virtune-ab-publ-virtune-has-completed-the-monthly-rebalancing-for-april-2026-of-its-virtune-crypto-altcoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) has completed the monthly rebalancing for April 2026 of its Virtune Crypto Altcoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910206829-virtune-ab-publ-virtune-har-genomf-rt-den-m-natliga-rebalanseringen-f-r-april-2026-av-virtune-crypto-altcoin-index-etp</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T08:06:34+00:00</news:publication_date>
        <news:title>Virtune AB (Publ) (&quot;Virtune&quot;) har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Altcoin Index ETP</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910188220-proper-hills-launches-ultra-slim-alloy-magnetic-power-bank-for-design-conscious-consumers</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T05:30:58+00:00</news:publication_date>
        <news:title>Proper Hills Launches Ultra-Slim Alloy Magnetic Power Bank for Design-Conscious Consumers</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/382df764-328b-4049-8389-ac0950f52367/medium/proper-hills-just-made-a-power-bank-thinner-than-a-pencil-th.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910177238-unbounded-vision-dreame-window-cleaning-robot-debuts-in-north-america-redefining-vertical-cleaning-with-precision-technology</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T04:17:56+00:00</news:publication_date>
        <news:title>Unbounded Vision: Dreame Window Cleaning Robot Debuts in North America, Redefining Vertical Cleaning with Precision Technology</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/d9c436d7-c9c5-46ff-8495-5a11d321f6a3/3-5.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910162333-lakefusion-raises-7-5m-seed-financing-to-redefine-master-data-management-mdm-natively-on-databricks</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T02:02:10+00:00</news:publication_date>
        <news:title>LakeFusion Raises $7.5M Seed Financing to Redefine Master Data Management (MDM) Natively on Databricks</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/78680f0e-2aae-4cb5-8bf0-8e3d8bb6b896/medium/lakefusion-raises-7-5m-seed-financing-to-redefine-master-dat.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910150844-novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/cecf4f80-22df-4bbf-b0a7-f50b9acf9495/medium/agc-biologics-and-novelty-nobility-representatives-meet.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910150881-agc</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1qYQ==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910150885-novelty-nobility-agc-biologics</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T00:00:00+00:00</news:publication_date>
        <news:title>노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1rbw==/tiny/AGC-Biologics-Inc-.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910145359-crypto-news-today-alphapepe-presale-ai-dex-hits-final-testing-whilst-bitcoin-price-prediction-points-to-120-000</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T23:30:00+00:00</news:publication_date>
        <news:title>Crypto News Today: AlphaPepe Presale AI DEX Hits Final Testing Whilst Bitcoin Price Prediction Points to $120,000</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/2c8b0156-2a64-4138-b75f-f7aaa8bdfd49/medium/alphapepe.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910130237-neuro-salt-under-investigation-full-pink-salt-trick-consumer-report-reveals-shocking-hidden-risks</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T20:52:12+00:00</news:publication_date>
        <news:title>Neuro Salt Under Investigation: Full &quot;Pink Salt Trick&quot; Consumer Report Reveals Shocking Hidden Risks</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/5b7201ce-5f4e-4a97-9fe8-95a77e66b2b7/medium/neuro-salt.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910111834-luma-glasses-unveiled-does-lumaglasses-smart-ai-glasses-really-works-read-luma-glasses-consumer-report</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T18:16:40+00:00</news:publication_date>
        <news:title>Luma Glasses Unveiled: Does LumaGlasses Smart AI Glasses Really Works? Read Luma Glasses Consumer Report! </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/c2a2f020-e4e2-491b-aa89-89d3efaa0309/medium/luma-glasses.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910074985-russian-oil-asset-fund-launches-public-website-and-solana-token-information-hub-for-roaf</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T13:00:00+00:00</news:publication_date>
        <news:title>Russian Oil Asset Fund Launches Public Website and Solana Token Information Hub for $ROAF</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/a1ac6677-6dcc-4559-8941-b2ce8d5537ad/small/555-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910068316-bsstrategy-introduces-ai-powered-trading-workspace-for-strategy-development-and-portfolio-management</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T12:00:00+00:00</news:publication_date>
        <news:title>BsStrategy Introduces AI-Powered Trading Workspace for Strategy Development and Portfolio Management</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/29228b48-2078-4e24-8423-55e6f010abde/medium/bsstrategy-logo.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910026702-stellarspace-stellt-bei-einer-auftaktveranstaltung-im-silicon-valley-produkte-der-neuen-generation-f-r-die-industrielle-automatisierung-vor</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T05:09:19+00:00</news:publication_date>
        <news:title>StellarSpace stellt bei einer Auftaktveranstaltung im Silicon Valley Produkte der neuen Generation für die industrielle Automatisierung vor</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/30183e94-1d9e-4c76-980e-bb4a59888b14/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910026705-stellarspace-presenta-i-prodotti-di-automazione-industriale-di-nuova-generazione-all-evento-di-lancio-nella-silicon-valley</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T05:09:19+00:00</news:publication_date>
        <news:title>StellarSpace presenta i prodotti di automazione industriale di nuova generazione all’evento di lancio nella Silicon Valley</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/670deeb7-29d8-4511-a37d-3bf43c3f7439/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/910026708-stellarspace-silikon-vadisi-lansman-etkinli-inde-yeni-nesil-end-striyel-otomasyon-r-nlerini-lk-defa-tan-tt</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-03T05:09:19+00:00</news:publication_date>
        <news:title>StellarSpace, Silikon Vadisi Lansman Etkinliğinde Yeni Nesil Endüstriyel Otomasyon Ürünlerini İlk Defa Tanıttı</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/Resource/Download/fcc7913a-5f01-4e26-8286-5362ebe4e600/image2.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.northdakotatechnologyreview.com/article/909991121-crypto-news-today-alphapepe-presale-nears-1-1m-raised-whilst-cardano-price-prediction-targets-5-00</loc>
      <news:news>
        <news:publication>
          <news:name>North Dakota Technology Review</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-02T23:15:00+00:00</news:publication_date>
        <news:title>Crypto News Today: AlphaPepe Presale Nears $1.1M Raised Whilst Cardano Price Prediction Targets $5.00</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/34d416a1-fa87-4a5c-abbc-3481d45ef3d6/medium/alphapepe.jpg</image:loc>
        </image:image>
    </url>
</urlset>
